FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
83 letters match. Newest first.
-
FoodDeggeh Foods, Inc.
FDA says Deggeh Foods sold supplement capsules and Moringa tea as unapproved drugs and violated manufacturing rules.
High risk -
DrugsHerbsens Botanicals
Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.
High risk -
FoodCAJ Food Products Inc.
CAJ Food Products marketed Biotta and Juice Performer juices with disease claims, making them unapproved new drugs, FDA says.
High risk -
DrugsAyuryoga, Inc.
FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.
High risk -
FoodMYA International, Inc.
FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.
High risk -
DrugsCrystal Clear Supplements
Crystal Clear Supplements took orders for tianeptine and other products FDA calls unapproved new drugs.
High risk -
FoodGlenn Burkett Naples Corporation
Glenn Burkett Naples Corporation sold colloidal silver and supplement products as unapproved drugs, including claims to treat COVID-19.
High risk -
FoodGeroNova Research Inc.
FDA warned GeroNova Research that disease claims on its Amazon store and social media make its carnitine and R-lipoic acid supplements unapproved, misbranded drugs.
Medium -
DevicesMedtronic, Inc.
FDA warns Medtronic over inadequate CAPA and complaint handling for MiniMed insulin pumps linked to retainer-ring failures and cybersecurity risks.
High risk -
DrugsNew Green Nutrition, Inc.
FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.
High risk -
FoodICA Health, LLC/Future Formulations, LLC
ICA Health sells five Dr. Wilson supplements with website claims that make them unapproved new drugs, FDA says.
Medium -
FoodSupplement Science Corp. d/b/a Condemned Labz
FDA warned Condemned Labz that five supplement products were unapproved new drugs and misbranded, and two were adulterated.
High risk -
FoodBrilliant Enterprises LLC
FDA warned Brilliant Enterprises that its mushroom products are unapproved new drugs because website and social media claims say they treat diseases.
Medium -
FoodPharmaganics LLC
FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.
High risk -
FoodPhytag Labs
FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.
Medium -
FoodNuturna International LLC
Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.
High risk -
FoodMetamune Inc
FDA and FTC warn Metamune over DiabetesSupport supplement claims to treat diabetes without approval.
High risk -
FoodLive Good Inc.
Live Good Inc. sold Berry Gen Sugar Control supplements as a diabetes treatment without FDA approval, making it an unapproved, misbranded drug.
High risk -
FoodRadhanite, LLC d/b/a Curalife Ltd
FDA and FTC say Curalife markets CuraLin supplement with unapproved diabetes-treatment claims.
High risk -
FoodAceva, LLC
Aceva, LLC marketed Sugar Balance supplement with unapproved diabetes and blood sugar drug claims, FDA says.
High risk -
FoodAr-Rahman Pharm LLC
FDA and FTC cite Ar-Rahman Pharm for Diabetes Support sold with unapproved diabetes-treatment claims.
High risk -
FoodLysulin, Inc.
Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.
High risk -
FoodHolistic Healer & Wellness Center, Inc.
FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.
High risk -
FoodTeaTaze, LLC
TeaTaze marketed eight teas with claims they treat diseases, including COVID-19, making them unapproved new drugs, FDA says.
High risk -
FoodNutrishus Brands, Inc.
FDA warned Nutrishus Brands that its RxSugar sweeteners were unapproved new drugs and misbranded foods due to website disease and health claims.
Low -
FoodPhoenix Nutritionals, Inc.
FDA warned Phoenix Nutritionals that disease-treatment claims on its supplement websites make eight products unapproved drugs, including COVID-19 claims.
High risk -
FoodJLM Nutritionals, Inc. dba JLM Nutrition—Super Naturals Health
FDA says JLM Nutritionals marketed five Super Naturals supplements as unapproved drugs with disease claims on websites, Amazon, and Facebook.
High risk -
FoodDRF LLC
FDA warned DRF LLC that Boston C, Mega-Dose Vitamin C, and Pixie Dust Magnesium were unapproved drugs promoted for treating cancer.
High risk -
FoodOmega Wonders LLC.
Omega Wonders LLC sells Cardia 7 and Tear Health supplements with disease claims, making them unapproved new drugs and misbranded.
Low -
FoodEU Natural Inc.
EU Natural's fertility supplements are unapproved new drugs because website claims treat infertility, PCOS, cancer and other diseases.
High risk -
FoodImmune & Genetics Protocols, LLC
FDA warned Immune & Genetics Protocols that website claims its Immune Bio Green Cell treats cancer, diabetes and HIV make it an unapproved new drug.
High risk -
FoodOrphic Nutrition
FDA warned Orphic Nutrition that its supplement capsules and gummies are unapproved new drugs because website claims say they treat diseases.
High risk -
FoodDuoc Thao Tre Xanh, LLC
FDA warned Duoc Thao Tre Xanh that its four herbal products are unapproved new drugs based on website disease claims.
High risk